Most of the huge groundswell for the two most common diabesity drugs — Eli Lilly’s tirzepatide and Novo Nordisk’s semaglutide — has been driven by
Read MoreTag: Weight
Here’s When Weight Loss Drugs Might Be Covered By Insurance
There’s been a massive shift in the conversation surrounding weight loss since GLP-1 agonist medications like Ozempic and Wegovy hit the mainstream in 2022. With
Read MoreEXPERT PITCH: WVU weight loss expert sees potential in new obesity drugs | WVU Today
Dr. Laura Davisson, professor and associate program director of Internal Medicine in the WVU School of Medicine and director of the Medical Weight Management Clinic
Read More/cloudfront-us-east-2.images.arcpublishing.com/reuters/UJ3AN24KIFJK5AFHR4HQ6HVAO4.jpg "How well-off Brits still buy Ozempic online for weight loss")
How well-off Brits still buy Ozempic online for weight loss
Despite curbs, people with means still buy diabetes drug for weight loss online Loophole allows clinicians to prescribe any drug they think will help their
Read More
Some doctors have stopped recommending weight loss. Here’s why : NPR
In an attempt to curb misdiagnosis or health care avoidance, some providers are encouraging overweight patients to exercise and eat healthily without addressing weight at
Read More
Presenting weight loss in a positive way linked to greater treatment uptake
November 10, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read More
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to Ozempic and Wegovy
The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to
Read More
A Q&A on the Mounjaro-Like Weight Loss Drug
The approval by the U.S. Food and Drug Administration (FDA) of the weight loss drug Zepbound (tirzepatide) will give millions of Americans with overweight and
Read More